Protection of natural infection against reinfection with SARS-CoV-2 JN.1 variant DOI
Hiam Chemaitelly, Peter Coyle, Mohamed Ali Ben Hadj Kacem

et al.

medRxiv (Cold Spring Harbor Laboratory), Journal Year: 2024, Volume and Issue: unknown

Published: Feb. 23, 2024

Abstract This study investigated the effectiveness of natural infection in preventing reinfection with JN.1 variant during a large wave Qatar, using test-negative case-control design. The overall previous was estimated at only 1.8% (95% CI: −9.3-12.6%). demonstrated rapid decline over time since infection, decreasing from 82.4% 40.9-94.7%) within 3 to less than 6 months after 50.9% −11.8-78.7%) subsequent months, and further dropping 18.3% −34.6-56.3%) months. Ultimately, it reached negligible level one year. findings show that protection against is strong among those who were infected last variants such as XBB*. However, this wanes rapidly entirely lost year infection. support considerable immune evasion by JN.1.

Language: Английский

COVID-19 testing, incidence, and positivity trends among school age children during the academic years 2020–2022 in the State of Qatar: special focus on using CDC indicators for community transmission to evaluate school attendance policies and public health response DOI Creative Commons
Mohamed Ghaith Al‐Kuwari, Azza Mustafa Mohammed, Jazeel Abdulmajeed

et al.

BMC Pediatrics, Journal Year: 2024, Volume and Issue: 24(1)

Published: May 30, 2024

Abstract Background There exists a gap in our understanding of the age-dependent epidemiological dynamics SARS-CoV-2 among school-age children comparison to adults within State Qatar. Additionally, there has been limited assessment timely implementation physical distancing interventions, notably national school closures, and their impact on infection trends. Methods We used database capture all records polymerase-chain-reaction (PCR) testing, rapid antigen tests (RAT) conducted at health care venues Qatar administered between August 26, 2020, 21, 2022, across age groups (≥ 5 years old). Study participants under 18 old were categorized into two brackets: (5–11) (12–17), aligning with Primary Preparatory/Secondary grade levels Qatar, respectively. assessed group testing rates, incidence positivity rates relation adults. These metrics compared CDC’s thresholds for COVID-19 community transmission. Results Throughout 2020–2021 2021–2022, total 5,063,405 6,130,531 respectively conducted. In year, 89.6% adults, while 13.7% following year. The overall test 2021–2022 5.8% 8.1%, Adolescents underwent fewest during full study period both young children. Using CDC indicators, we found that adolescents can significantly contribute elevated potentially driving transmission upon relaxation social restrictions. Conclusion It is crucial acknowledge potential higher youth when formulating control strategies making decisions regarding closures. Employing data-driven indicators monitor important informing decision-making. approaches also enable prompt mitigation measures future pandemics.

Language: Английский

Citations

0

Prevalence of hepatitis A virus among migrant workers in Qatar: A national study DOI Creative Commons

Nadin Younes,

Hiam Chemaitelly, Parveen B. Nizamuddin

et al.

PLoS ONE, Journal Year: 2024, Volume and Issue: 19(7), P. e0306753 - e0306753

Published: July 9, 2024

Background Hepatitis A virus (HAV) is the predominant cause of acute viral hepatitis worldwide; however, data on HAV antibody prevalence (seroprevalence) among migrant populations are limited. This study aimed to investigate seroprevalence Qatar’s craft and manual workers (CMWs), constituting approximately 60% country’s population. Methods testing was conducted stored serum specimens obtained from CMWs during a nationwide severe respiratory syndrome coronavirus 2 (SARS-CoV-2) population-based cross-sectional survey between July 26 September 9, 2020. Associations with infection were investigated through regression analyses. Results Of 2,607 test results, 2,393 positive, 214 negative. The estimated 92.0% (95% CI: 90.9–93.1%). generally high but exhibited some variation, ranging 70.9% 62.4–78.2%) Sri Lankans 99.8% 98.2–99.9%) Pakistanis. multivariable analysis identified age, nationality, educational attainment as statistically significant factors associated infection. Relative aged ≤29 years, adjusted relative risk (ARR) 1.06 1.03–1.10) in 30–39 years reached 1.15 1.10–1.19) those ≥50 years. In comparison Indians, ARR lower Lankans, assessed at 0.81 0.72–0.91), higher Nepalese 1.07 1.04–1.11), Bangladeshis 1.10 1.07–1.13), Pakistanis 1.12 1.09–1.15), Egyptians 1.08–1.23). No evidence for differences found by geographic location or occupation. Conclusions CMW population very high, over nine out every ten individuals having been exposed this infection, likely childhood.

Language: Английский

Citations

0

Assessing Healthy Vaccinee Bias in COVID-19 Vaccine Effectiveness Studies: A National Cohort Study in Qatar DOI Open Access
Hiam Chemaitelly, Houssein H. Ayoub, Peter Coyle

et al.

medRxiv (Cold Spring Harbor Laboratory), Journal Year: 2024, Volume and Issue: unknown

Published: July 29, 2024

Abstract Background This study investigated the presence of healthy vaccinee effect—the imbalance in health status between vaccinated and unvaccinated individuals—in two COVID-19 vaccine effectiveness studies involving primary series booster vaccinations. It also examined temporal patterns variability this effect across different subpopulations by analyzing association vaccination non-COVID-19 mortality Qatar. Methods Two matched, retrospective cohort assessed incidence death national cohorts individuals with a versus no (two-dose analysis), three-dose (booster) (three-dose from January 5, 2021, to April 9, 2024. Results The adjusted hazard ratio (aHR) for was 0.76 (95% CI: 0.64-0.90) two-dose analysis 0.85 0.67-1.07) analysis. In first six months follow-up analysis, aHR 0.35 0.27-0.46); however, combined all subsequent periods showed an 1.52 1.19-1.94). 0.31 0.20-0.50); 1.37 1.02-1.85). overall third-dose vaccinations against severe, critical, or fatal 95.9% 94.0-97.1) 34.1% −46.4-76.7), respectively. Subgroup analyses that is pronounced among those aged 50 years older more clinically vulnerable severe COVID-19. Conclusion A strong observed following vaccination. may have stemmed lower likelihood seriously ill, end-of-life individuals, less mobile elderly populations.

Language: Английский

Citations

0

COVID-19 epidemic investigation study of a follow-up cohort of patients with diabetic kidney disease DOI Creative Commons
Qian Wang, Zheyi Dong, Weiguang Zhang

et al.

Frontiers in Cellular and Infection Microbiology, Journal Year: 2024, Volume and Issue: 14

Published: Aug. 20, 2024

Introduction The impact of coronavirus disease 2019 (COVID-19) on diabetic kidney (DKD) patients in China is not fully understood. This study aimed to investigate infection status a DKD cohort post-renal biopsy and analyze vaccination rates, as well symptom severity, across various renal pathologies patients. Methods epidemiological survey, centered COVID-19, employed Chinese puncture follow-up cohort. A customized questionnaire enabled standardized data gathering. It collected clinical characteristics, statuses, diverse pathological types. analyzed the relationship between statuses types, evaluating characteristics treatment outcomes with infections. Results In total, 437 from 26 provinces were followed up for median 44.6 ± 20 months. COVID-19 infection, vaccination, novel pneumonia (NCP) rates 73.68%, 59.3%, 6.63%, respectively. Ten NCP had severe or died COVID-19. Renal pathology revealed that 167 (38.22%) nephropathy (DN), 171 (39.13%) non-diabetic (NDRD), 99 DN NDRD (22.65%). group lowest (54.5%), highest all-cause mortality (3.6%), endpoint (34.10%). Compared who vaccinated pre-infection (117 cases), (198 cases) reduced (6.6% vs. 13.7%), severity (1.0% 3.4%), (9.10% 31.60%) rates. Conclusion Vaccination can prevent diminish DKD; therefore, increasing particularly important. Clinical Trial registration ClinicalTrails.gov, NCT05888909.

Language: Английский

Citations

0

Protection of natural infection against reinfection with SARS-CoV-2 JN.1 variant DOI
Hiam Chemaitelly, Peter Coyle, Mohamed Ali Ben Hadj Kacem

et al.

medRxiv (Cold Spring Harbor Laboratory), Journal Year: 2024, Volume and Issue: unknown

Published: Feb. 23, 2024

Abstract This study investigated the effectiveness of natural infection in preventing reinfection with JN.1 variant during a large wave Qatar, using test-negative case-control design. The overall previous was estimated at only 1.8% (95% CI: −9.3-12.6%). demonstrated rapid decline over time since infection, decreasing from 82.4% 40.9-94.7%) within 3 to less than 6 months after 50.9% −11.8-78.7%) subsequent months, and further dropping 18.3% −34.6-56.3%) months. Ultimately, it reached negligible level one year. findings show that protection against is strong among those who were infected last variants such as XBB*. However, this wanes rapidly entirely lost year infection. support considerable immune evasion by JN.1.

Language: Английский

Citations

0